Want to see DE:AAQ1 full AI Analyst Report?
aap Implantate (AAQ1) Ratios
aap Implantate Ratios
DE:AAQ1's free cash flow for Q2 2026 was $-156.50K. For the 2026 fiscal year, DE:AAQ1's free cash flow was decreased by $-116.00K and operating cash flow was $-40.50K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Jun 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.07 | 1.96 | 1.81 | 2.03 | 2.10 |
| Quick Ratio | 1.04 | 1.06 | 0.86 | 0.61 | 0.95 |
| Cash Ratio | 0.17 | 0.46 | 0.27 | 0.04 | 0.33 |
| Solvency Ratio | -0.14 | -0.33 | -0.41 | -0.12 | -0.07 |
| Operating Cash Flow Ratio | -0.37 | -0.25 | -0.63 | -0.34 | -0.39 |
| Short-Term Operating Cash Flow Coverage | -7.51 | -5.04 | -5.34 | -1.65 | -1.69 |
| Net Current Asset Value | $ 2.93M | $ 3.51M | $ -69.00K | $ 3.78M | $ 3.14M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.11 | 0.27 | 0.16 | 0.22 |
| Debt-to-Equity Ratio | 0.11 | 0.16 | 0.49 | 0.25 | 0.40 |
| Debt-to-Capital Ratio | 0.10 | 0.14 | 0.33 | 0.20 | 0.28 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | 0.20 | 0.02 | 0.07 |
| Financial Leverage Ratio | 1.58 | 1.51 | 1.80 | 1.58 | 1.80 |
| Debt Service Coverage Ratio | -3.31 | -4.08 | -4.61 | -0.34 | -0.09 |
| Interest Coverage Ratio | 0.00 | -16.08 | -31.14 | -9.11 | -7.88 |
| Debt to Market Cap | 0.01 | 0.02 | 0.49 | 0.17 | 0.16 |
| Interest Debt Per Share | 0.07 | 0.19 | 0.66 | 0.60 | 1.14 |
| Net Debt to EBITDA | -0.51 | 0.29 | -1.17 | -1.87 | -5.72 |
| Profitability Margins | |||||
| Gross Profit Margin | 86.40% | 87.45% | 84.83% | 91.84% | 19.05% |
| EBIT Margin | -20.00% | -25.04% | -43.96% | -28.14% | -19.43% |
| EBITDA Margin | -5.06% | -9.78% | -29.90% | -13.62% | -4.27% |
| Operating Profit Margin | -20.00% | -22.27% | -45.03% | -29.42% | -32.40% |
| Pretax Profit Margin | 0.00% | -26.43% | -45.41% | -31.37% | -23.54% |
| Net Profit Margin | -20.80% | -29.75% | -44.65% | -22.26% | -20.73% |
| Continuous Operations Profit Margin | 0.00% | -29.75% | -44.65% | -22.26% | -20.73% |
| Net Income Per EBT | 0.00% | 112.56% | 98.33% | 70.97% | 88.06% |
| EBT Per EBIT | 0.00% | 118.65% | 100.83% | 106.64% | 72.65% |
| Return on Assets (ROA) | -18.91% | -22.92% | -26.32% | -12.68% | -10.99% |
| Return on Equity (ROE) | -29.90% | -34.70% | -47.25% | -19.99% | -19.74% |
| Return on Capital Employed (ROCE) | -25.27% | -24.03% | -35.04% | -23.04% | -23.72% |
| Return on Invested Capital (ROIC) | 0.00% | -21.13% | -30.66% | -14.47% | -18.49% |
| Return on Tangible Assets | -22.07% | -26.01% | -29.37% | -14.15% | -12.22% |
| Earnings Yield | -13.16% | -28.98% | -74.44% | -31.89% | -17.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.23 | 5.84 | 5.06 | 4.11 | 3.63 |
| Payables Turnover | 0.91 | 0.68 | 0.80 | 0.45 | 4.16 |
| Inventory Turnover | 0.43 | 0.37 | 0.39 | 0.12 | 1.35 |
| Fixed Asset Turnover | 5.77 | 3.68 | 1.82 | 2.65 | 2.32 |
| Asset Turnover | 0.91 | 0.77 | 0.59 | 0.57 | 0.53 |
| Working Capital Turnover Ratio | 2.95 | 2.98 | 2.42 | 1.82 | 1.95 |
| Cash Conversion Cycle | 522.39 | 496.35 | 565.04 | 2315.63 | 284.00 |
| Days of Sales Outstanding | 69.79 | 62.45 | 72.15 | 88.75 | 100.69 |
| Days of Inventory Outstanding | 851.52 | 974.13 | 947.20 | 3036.10 | 271.01 |
| Days of Payables Outstanding | 398.92 | 540.23 | 454.31 | 809.21 | 87.69 |
| Operating Cycle | 921.31 | 1036.58 | 1019.35 | 3124.85 | 371.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.10 | -0.11 | -0.36 | -0.32 | -0.50 |
| Free Cash Flow Per Share | -0.16 | -0.15 | -0.41 | -0.40 | -0.61 |
| Dividend Paid and CapEx Coverage Ratio | -1.98 | -3.41 | -7.37 | -3.90 | -4.72 |
| Capital Expenditure Coverage Ratio | -1.98 | -3.41 | -7.37 | -3.90 | -4.72 |
| Operating Cash Flow Coverage Ratio | -1.46 | -0.65 | -0.57 | -0.60 | -0.49 |
| Operating Cash Flow to Sales Ratio | -0.11 | -0.09 | -0.26 | -0.16 | -0.20 |
| Free Cash Flow Yield | -10.93% | -11.61% | -49.35% | -29.57% | -20.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.47 | -3.45 | -1.34 | -3.14 | -5.85 |
| Price-to-Sales (P/S) Ratio | 1.58 | 1.03 | 0.60 | 0.70 | 1.21 |
| Price-to-Book (P/B) Ratio | 2.27 | 1.20 | 0.63 | 0.63 | 1.15 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.15 | -8.61 | -2.03 | -3.38 | -4.93 |
| Price-to-Operating Cash Flow Ratio | -13.78 | -11.14 | -2.30 | -4.25 | -5.97 |
| Price-to-Earnings Growth (PEG) Ratio | 0.15 | 0.09 | -0.03 | 0.14 | 0.07 |
| Enterprise Value Multiple | -31.77 | -10.20 | -3.18 | -7.00 | -34.07 |
| Enterprise Value | 20.08M | 12.18M | 10.90M | 10.98M | 17.72M |
| EV to EBITDA | -31.77 | -10.20 | -3.18 | -7.00 | -34.07 |
| EV to Sales | 1.61 | 1.00 | 0.95 | 0.95 | 1.46 |
| EV to Free Cash Flow | -9.30 | -8.37 | -3.21 | -4.62 | -5.92 |
| EV to Operating Cash Flow | -14.00 | -10.83 | -3.64 | -5.80 | -7.17 |
| Tangible Book Value Per Share | 0.48 | 0.87 | 1.06 | 1.80 | 2.13 |
| Shareholders’ Equity Per Share | 0.63 | 1.06 | 1.31 | 2.15 | 2.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.13 | 0.02 | 0.29 | 0.12 |
| Revenue Per Share | 0.90 | 1.24 | 1.38 | 1.93 | 2.48 |
| Net Income Per Share | -0.19 | -0.37 | -0.62 | -0.43 | -0.51 |
| Tax Burden | 0.00 | 1.13 | 0.98 | 0.71 | 0.88 |
| Interest Burden | 0.00 | 1.06 | 1.03 | 1.11 | 1.21 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.00 | 0.39 | 0.23 | 0.20 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Income Quality | 0.55 | 0.31 | 0.58 | 0.74 | 0.98 |
Currency in EUR